Compare FMC Corp (FMC) vs Schlumberger NV (SLB) Price & Performance

FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.

The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.

SLB trades at $47.21, down 0.69% on the day, with a bullish technical signal supported by moving averages. The company reported consistent earnings beats in recent quarters, with Q2 2026 EPS expected at $0.52. Recent strategic alliances with Liberty Energy for data center power solutions and major contract wins like the Baleine Phase 3 EPC deal highlight growth initiatives. Valuation metrics show a P/E of 20.95 and P/S of 1.95, while profitability remains solid with a net income margin of 9.26% and ROE of 14.57%.

The outlook for SLB is positive, driven by contract expansions and diversification into data center infrastructure, offering upside to the $62.83 consensus price target. Risks include oil price volatility and execution challenges in new ventures. Analyst sentiment is strongly bullish with 84.85% buy ratings, though investors should monitor debt levels and macroeconomic pressures on energy demand.